Dell Stock Has Nearly Doubled in 2026. UBS Analysts Say It Likely Won’t Go Any Further.
Dell Technologies by Poetra_RH via Shutterstock Dell Technologies (DELL) has seen its stock almost double this year amid…
Psoriatic Arthritis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight
The Key Psoriatic Arthritis Companies in the market include – Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB,…
Antisense Oligonucleotide Therapeutics Pipeline Grows as 70+ Pharma Companies Advance Novel Treatments for Genetic and Rare Diseases, Finds DelveInsight
“Antisense Oligonucleotide Therapeutics Pipeline Insight” The Antisense Oligonucleotide landscape features 70+ key companies, including Novartis, Wave Life Sciences,…
Nestlé Stock Jumped Despite Weak Sales. Here’s Why.
Blurred food and drink isles by themorningglory via iStock With roots dating back to 1866, Nestlé (NSRGY) is…
Liver Cancer Pipeline Grows as 70+ Pharma Companies Advance Novel Liver Cancer Therapies, Finds DelveInsight
“Liver Cancer Pipeline Insight” There are 70+ key companies, including Can-Fite BioPharma, Yiviva, Tvardi Therapeutics, Biosion, Novartis, Roche,…
Antisense Oligonucleotide Therapeutics Pipeline Grows as 70+ Pharma Companies Advance Novel Treatments for Genetic and Rare Diseases, Finds DelveInsight
“Antisense Oligonucleotide Therapeutics Pipeline Insights” The Antisense Oligonucleotide landscape features 70+ key companies, including Novartis, Wave Life Sciences,…
Liver Cancer Pipeline Grows as 70+ Pharma Companies Advance Novel Liver Cancer Therapies, Finds DelveInsight
“Liver Cancer Pipeline Insight” There are 70+ key companies, including Can-Fite BioPharma, Yiviva, Tvardi Therapeutics, Biosion, Novartis, Roche,…
Antisense Oligonucleotide Therapeutics Pipeline Grows as 70+ Pharma Companies Advance Novel Treatments for Genetic and Rare Diseases, Finds DelveInsight
“Antisense Oligonucleotide Therapeutics Pipeline Insights” The Antisense Oligonucleotide landscape features 70+ key companies, including Novartis, Wave Life Sciences,…
Amazon (AMZN) Gets PT Upgrades From UBS, BMO Capital
Amazon (AMZN) shares received a couple shots of confidence Thursday morning, as a pair of analyst firms upgraded…
Glencore Stock Is Up 120% in the Past Year. Can It Survive the Iran War?
Glencore (GLNCY) has strong momentum and is trading at new all-time highs.Shares are up more than 120% over…
Primary Biliary Cholangitis Pipeline Set for Major Breakthroughs by 2026 with 25+ Therapies and Strong Clinical Momentum from GlaxoSmithKline, Novartis, and CymaBay Therapeutics
“Primary Biliary Cholangitis Pipeline” Primary Biliary Cholangitis Companies such as Genfit, Zydus Discovery, Ohara Pharmaceutical, Chia Tai Tianqing…
Chubb Limited Earnings Preview: What to Expect
Valued at a market cap of $127.6 billion, Chubb Limited (CB) is one of the world’s largest publicly traded property…